We investigated characteristics, causes and treatment of postpartum haemorrhage (PPH) in a random sample of 294 women's first and second pregnancies involving at least one PPH. Among 588 pregnancies, PPH affected 169 first pregnancies, 105 second pregnancies only and recurrent PPH affected 48 pregnancies. In 34% of PPHs, atony was the primary cause. Second pregnancy PPH involved increased pharmacological therapy, blood transfusion and median blood loss. It is important to ascertain PPH history in parous women and be prepared for PPH recurrence. 
Introduction
Postpartum haemorrhage (PPH) is one of the leading causes of maternal morbidity and mortality. Recent research indicates that the incidence of postpartum haemorrhage and associated adverse outcomes in developed countries are increasing. [1] , [2] Canadian and US studies suggest that such increases are driven by increases in uterine atony which is purported to be the cause of three-quarters of postpartum haemorrhages in high resource settings. [3 4 ] However, the accuracy of reporting of the cause of PPH has been questioned. [5] Nulliparity and grand multiparity (≥5 births) have been demonstrated to be risk factors for PPH, [3 6 7] however where PPH occurs in a second pregnancy it is not known whether the aetiology and treatment differs from that in a first pregnancy.
Furthermore, among women having a PPH, it is not clear whether a subsequent PPH involves more severe bleeding. The aim of this study was to investigate the characteristics, causes and treatment of PPH in first and second pregnancies.
Methods
We utilised data collected in a review of PPH among 294 women with first and second pregnancies (representing 588 pregnancy records) and at least one PPH. The details of this study are reported elsewhere. [5] Briefly, we selected a random sample of 600 first and second birth medical records for 300 women giving birth in New South Wales (2002) (2003) (2004) (2005) (2006) where hospital data reported a PPH after either or both pregnancies.
Data were abstracted from delivery summaries, progress notes, operation and anaesthetic charts in medical records.
Postpartum haemorrhage was defined as blood loss of ≥ 500 mL following vaginal birth or ≥ 750 mL following caesarean section (ICD-10AM blood loss criteria) [8] A higher proportion of second pregnancy PPHs were given pharmacological treatment, in particular an oxytocin infusion or bolus, than those occurring following a first pregnancy (Table 1) . Similarly a higher proportion of manual removal of the placenta and transfusions were performed following second pregnancy PPHs (Table 1 ). There were no uterine arterial ligations, embolisations, B-lynch sutures or hysterectomies documented in the study population. Among women with a recurrent PPH, 91% had pharmacological treatment of both haemorrhages. A blood or blood component transfusion was initiated following 31 (7.7%) PPHs. There were 2 transfusions recorded following pregnancies that were not recorded as having PPHs but which involved a haematoma and intra-peritoneal bleeding.
Discussion
Findings of this study indicate that the role of uterine atony as a primary cause of PPH may be over-estimated in some studies, that there are often multiple causes of PPH present and that PPH in subsequent pregnancies may potentially be more severe than a first PPH.
In our study, approximately one in three PPHs were primarily related to uterine atony, a lower proportion than reported in the USA or Canada where reporting is based on 
Conclusion
Uterine atony remains a leading cause of primary PPH and there is some indication that a subsequent haemorrhage may also involve atony. Importantly, our study found a trend towards increased blood loss at a subsequent haemorrhage. These results highlight the importance of ascertaining pregnancy history in parous women and the need for prevention and preparedness for what is often an unexpected obstetric emergency for all pregnant women.
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